The forecast for the re-import of antisera and other blood fractions to Italy indicates a consistent upward trend from 2024 to 2028, with an increase in volume from 67.46 thousand kilograms in 2024 to 77.11 thousand kilograms in 2028. This reflects a steady year-on-year growth rate, averaging a compound annual growth rate (CAGR) over these five years. In 2023, the actual volume stood slightly lower than the forecasted 2024 value, showcasing the beginning of a positive trajectory.

Future trends to watch include:

Potential market changes due to advancements in medical technology and biotech innovations.
Shifts in global trade policies that might impact import strategies and costs.
Italy's healthcare and pharmaceutical landscape developments that could alter demand levels.